Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
STRO
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -30.2%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
sutro
biopharma
nasdaq
last
price
analysts
ratings
high
rating
trading
2023
announced
cancer
bullish
period
compared
bearish
analyst
therapeutics
nyse
STRO
Sutro Biopharma, Inc.